With a rich background in finance and experience in the pharmaceutical sector, including roles at bluebird bio and Jubilant Pharma, Krawtschuk is expected to bring valuable insight to Eagle’s ...

Eagle Pharmaceuticals (EGRX) announced the appointment of Christopher ... Most recently, Mr. Krawtschuk served as CFO and Treasurer of bluebird bio. Published first on TheFly – the ultimate source for ...

Atrial arrhythmias were found in 26% of patients with sickle cell disease (SCD), with a significant association with stroke history. Early detection and treatment of atrial arrhythmias may help ...

Bluebird priced the treatment at a considerable ... One of the more challenging endeavors investors in biotech and pharma face is estimating peak sales. Professional analysts are at times ...

In this article, we are going to take a look at where bluebird bio, Inc. (NASDAQ:BLUE) stands against other most promising ...

Nobias Therapeutics, a clinical-stage company developing novel small-molecule therapeutics for rare diseases, has announced its intent to focus its resources on its development programs following ...

Almost a year after two historic approvals, Pfizer is pulling a sickle cell disease treatment from the market, and the ...

BEAM-101 seems to be competitive with approved sickle cell treatments, William Blair analysts said in a note to investors, ...

Visionaire Research & Education, an innovator in recruiting patients for veterinary clinical studies, is proud to announce the launch of its new website, vrande.com. This unique website explains how ...

bluebird had set an initial price of $1.8 million ... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.

Shares in bluebird ticked up following the announcement. Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.

Bluebird Bio, Vertex Energy And Other Big Stocks Moving Lower On Tuesday U.S. stocks traded higher, with the Dow Jones index gaining around 150 points on Tuesday. Shares of bluebird bio, Inc ...